Saturday, July 08, 2017 6:22:30 AM
$EIGR
Revisiting this here, on my watch for a 2H play.
-Loaded with catalyst next 12 months, 5 P2 readouts all orphin indications.
-Cash 45M est, call is Q3-18
-Market Cap 64M
-low floater 8m shares
-institutions owns 70%
-Defined catalyst date for PAH, 4 billion market today. Company will have last patient visit in Ocotber for their P2 trial with "topline results at JPM Conference in 2nd week of January." $EIGR on my watch for Fall purchase as we get closer to several catalysts.
Jefferies Conf presentation:
Jefferies Presentation June 7
-BioHunter
@TheBio_Hunter
Not a reccomendation to buy or sell, DD only
Revisiting this here, on my watch for a 2H play.
-Loaded with catalyst next 12 months, 5 P2 readouts all orphin indications.
-Cash 45M est, call is Q3-18
-Market Cap 64M
-low floater 8m shares
-institutions owns 70%
-Defined catalyst date for PAH, 4 billion market today. Company will have last patient visit in Ocotber for their P2 trial with "topline results at JPM Conference in 2nd week of January." $EIGR on my watch for Fall purchase as we get closer to several catalysts.
Jefferies Conf presentation:
Jefferies Presentation June 7
-BioHunter
@TheBio_Hunter
Not a reccomendation to buy or sell, DD only
-BioHunter
Twitter: @TheBio_Hunter
Join the InvestorsHub Community
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
